139 related articles for article (PubMed ID: 1910125)
1. Urinary procoagulant and fibrinolytic activity in human glomerulonephritis. Relationship with renal function.
Colucci M; Semeraro N; Montemurro P; Chiumarulo P; Triggiani R; Morrone LF; Schena FP
Kidney Int; 1991 Jun; 39(6):1213-7. PubMed ID: 1910125
[TBL] [Abstract][Full Text] [Related]
2. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
Shibata K; Dohi K; Fujii Y; Ishikawa H
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
[TBL] [Abstract][Full Text] [Related]
3. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
4. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
5. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.
Idell S; James KK; Levin EG; Schwartz BS; Manchanda N; Maunder RJ; Martin TR; McLarty J; Fair DS
J Clin Invest; 1989 Aug; 84(2):695-705. PubMed ID: 2788176
[TBL] [Abstract][Full Text] [Related]
6. Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
Ekberg M; Pandolfi M
Br Med J; 1975 Apr; 2(5961):17-9. PubMed ID: 48398
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
8. [Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].
Smyr KV; Shcherbak AV; Kozlovskaia LV; Sokolova IA; Bobkova IN; Podorol'skaia LV
Ter Arkh; 2010; 82(1):47-51. PubMed ID: 20364701
[TBL] [Abstract][Full Text] [Related]
9. Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes.
Krishnamurti C; Alving B
Rev Infect Dis; 1989; 11 Suppl 4():S843-6. PubMed ID: 2501855
[TBL] [Abstract][Full Text] [Related]
10. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N
Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F
Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963
[TBL] [Abstract][Full Text] [Related]
12. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
13. Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage.
Idell S; Peters J; James KK; Fair DS; Coalson JJ
J Clin Invest; 1989 Jul; 84(1):181-93. PubMed ID: 2738151
[TBL] [Abstract][Full Text] [Related]
14. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
Sindet-Pedersen S
Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
[TBL] [Abstract][Full Text] [Related]
15. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
16. Blood fibrinolysis and the response to desmopressin in glomerulonephritis.
Brommer EJ; Van den Wall Bake AW; Dooijewaard G; van Loon BJ; Emeis JJ; Weening JJ
Thromb Haemost; 1994 Jan; 71(1):19-25. PubMed ID: 8165642
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
18. Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas.
Kirchheimer JC; Huber K; Wagner O; Binder BR
Br J Haematol; 1987 May; 66(1):85-9. PubMed ID: 3109463
[TBL] [Abstract][Full Text] [Related]
19. Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury.
Idell S; Peterson BT; Gonzalez KK; Gray LD; Bach R; McLarty J; Fair DS
Am Rev Respir Dis; 1988 Nov; 138(5):1282-94. PubMed ID: 3202484
[TBL] [Abstract][Full Text] [Related]
20. Influence of homocysteine on fibrin network lysis.
Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
